Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
20–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Body mass index (BMI): 18 to 27 kg/m 2
Female subjects must be postmenopausal for at least 1 year, surgically sterile, or using a reliable method of contraception at screening.
Male subjects must be willing to use accepted contraceptive methods, avoid unprotected sex, and donating sperm until 3 months after drug administration.
You may not be if
Clinically relevant disease and/or abnormalities (past or present)
Clinically relevant abnormalities in physical examinations,vital signs,clinical chemistry, hematology or urinalysis at screening as judged by the investigator
Use of any prescription medication within 14 days of Day 1
Use of over-the-counter (OTC) medication (with the exception of acetaminophen), vitamin/nutritional supplements and herbal preparations within 14 days of Day 1
Smoking in excess of 5 cigarettes per day or the equivalent within 28 days of Day 1
Clareo Health | AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects